MedPath

Extend Biosciences Inc.

Extend Biosciences Inc. logo
πŸ‡ΊπŸ‡ΈUnited States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:1

Trial Phases

2 Phases

Phase 1:1
Phase 2:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)β€’ Click on a phase to view related trials

Phase 1
1 (50.0%)
Phase 2
1 (50.0%)

A Phase 2 Trial Investigating the Safety, Tolerability and Efficacy of EXT608 in Adults With Hypoparathyroidism

Phase 2
Recruiting
Conditions
Hypoparathyroidism
Interventions
Other: Placebo
First Posted Date
2025-05-25
Last Posted Date
2025-05-25
Lead Sponsor
Extend Biosciences Inc.
Target Recruit Count
35
Registration Number
NCT06988670
Locations
πŸ‡¦πŸ‡·

Trial Site, Buenos Aires, Caba, Argentina

A Phase 1 Study of EXT608 in Healthy Adults

Phase 1
Completed
Conditions
Safety Issues
Interventions
Other: Placebo
First Posted Date
2022-06-07
Last Posted Date
2025-02-04
Lead Sponsor
Extend Biosciences Inc.
Target Recruit Count
24
Registration Number
NCT05408663
Locations
πŸ‡ΊπŸ‡Έ

PRA, Lenexa, Kansas, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.